Skip to main content

Table 1 Characteristics of participants. Age is described as mean and standard deviation

From: Safety and effectiveness of propranolol in severely burned patients: systematic review and meta-analysis

No. Study Group Total number of randomized patients Age TBSA (%) of patients to be included Country Socio-demographics
1 Williams 2011 [29] Propranolol 125 7 (5) Burns >30% USA Not described
Standard care 215 8 (5)
2 W Norbury 2007 [28] Propranolol 33 Not described Burns >40% USA Not described
Standard care 33 Not described
3 Wurzer 2015 [30] Propranolol 43 Not described Burns >30% USA Not described
Standard care 39
4 Ali 2014 [21] Propranolol 21 Not described Burns >30% USA Not described
Standard care 21
5 Komak 2012 [26] Propranolol 29 Not described Burns >40% USA Not described
Standard care 35
6 Ali 2015 [22] Propranolol 35 41 (14) Burns >30% USA Not described
Standard care 34 38 (16)
7 Herndon 2012 [24] Propranolol 90 7 (5) Burns >30% USA Majority of participants were Hispanic: 97% in the control group and 91% in the propranolol group
Standard care 89 7 (5)
8 Akbar Mohammadi 2009 [27] Propranolol 37 27.21 (9.73) Burns 20–50% Iran Not described
Standard care 42 24.54 (12.06)
9 Jeschke 2007 [25] Propranolol 102 7.2 (0.6) Burns >40% USA Not described
Standard care 143 7.8 (0.4)
10 Herndon 2001 [23] Propranolol 12 6.6 (1.5) Burns >40% USA Not described
Standard care 12 7.8 (1.4)